IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Necrotizing Enterocolitis

In brief

IBP-9414 will be evaluated in preterm infants with a birth weight of 500-1500g, compared to placebo with regards to efficacy and safety in the prevention of necrotizing enterocolitis.

Key facts

Study ID
NCT03978000
Run by
Infant Bacterial Therapeutics
People needed
2158
Starts
2019-07-04
Expected to finish
2024-07-01
Last updated by the study team
2024-04-12

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.